trial

Exercise and Olanzapine-samidorphan

NCTId NCT06740890
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Recruiting
Enrollment 30 (estimated)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2027-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Recruiting
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2025-06-26
Primary completion
2027-04
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Olanzapine

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor

Sites

1 total
New York, United States

Facts & assertions

4 sourced
Enrollment
30
Phase
PHASE4
Primary Completion Date
2027-04
Status
RECRUITING
relationships
The graph out of here
drug
Olanzapine
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
Bipolar Disorder I or II
indication